Follow DNDi on LinkedInFollow DNDi on TwitterFollow DNDi on Facebook

About Us

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for Neglected Diseases.

See DNDi's vision&mission and objectives.


     alt To learn more about DNDi's activities and patients, download our short Presentation Brochure!     
   
        alt altalt altalt altJapanese
 



DNDi is working on the following diseases: In 2011, DNDi started taking on specific projects for two new disease areas:
Working in partnership with private industry, public institutions, academia and NGOs, DNDi has built the largest ever R&D portfolio for the kinetoplastid diseases and has currently underway five projects in Implementation stage, seven in the clinical, and seven in the pre-clinical.
To date, DNDi has successfully delivered
DNDi initiates and coordinates drug R&D projects in collaboration with
  • the international research community
  • the public sector
  • the pharmaceutical industry
  • and other relevant partners.
DNDi is also working to strengthen existing capacities in disease-endemic countries.
Learn more about DNDi's

and 7 DNDi regional offices in North America, Kenya, India, Brazil, Malaysia, Japan and DRC

See DNDi Worldwide


Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License